|41.68|| +0.23 / +0.55%|
Alere, Inc. develops, manufactures and markets consumer and professional medical diagnostic products. The company's products and services focus on cardiology, infectious disease, women's health, oncology, and toxicology. Its portfolio also includes a broad array of health information solutions that increase access to critical health data, provide clinical decision support, and facilitate more comprehensive performance reporting and analysis. The company operates its business through the following segments: Professional Diagnostics, Health Information Solutions, and Consumer Diagnostics. The Professional Diagnostics segment includes an array of innovative rapid diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The Health Information Solutions segment provides comprehensive, integrated programs and services focused on wellness, disease and condition management, productivity enhancement and informatics, all designed to reduce health-related costs and enhance the health and quality of life of the individuals. The Consumer Diagnostics segment manufactures products for SPD Swiss Precision Diagnostics, the company's joint venture with The Procter & Gamble Co. Its Consumer Diagnostic products consist of First Check brand of over-the-counter drug tests for at-home testing for up to seven illicit drugs and five prescription drugs, as well as First Check brand over-the-counter tests for cholesterol monitoring. Alere was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Waltham, MA.
|Namal Nawana||President, Chief Executive Officer & Director|
|Mark Gladwell||Senior Vice President-Global Operations|
|James F. Hinrichs||Chief Financial Officer & Executive Vice President|
|Renuka Uppaluri||Senior Vice President-Research & Development|
|Ellen V. Chiniara||Secretary, Chief Ethics & Compliance Officer|